Ligand validation:2XZK

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2XZK_GOL_B_505	74%	85%	0.11	0.939	0.33	0.41	-	-	0	0	100%	1
2XZK_GOL_B_504	56%	82%	0.125	0.895	0.36	0.43	-	-	1	0	100%	1
2XZK_GOL_B_506	52%	84%	0.126	0.884	0.4	0.36	-	-	0	0	100%	1
2XZK_GOL_A_503	32%	63%	0.162	0.834	0.34	1.05	-	-	0	0	100%	1
2XZK_GOL_B_503	3%	80%	0.328	0.671	0.38	0.47	-	-	0	0	100%	1
4M4N_GOL_B_504	65%	88%	0.12	0.921	0.34	0.32	-	-	0	0	100%	1
4M4V_GOL_A_506	17%	92%	0.154	0.73	0.37	0.17	-	-	2	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
4Q6J_GOL_A_306	100%	33%	0.026	0.995	0.71	1.9	-	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.